Takara Bio Inc (4974)

Tokyo
Currency in JPY
852.0
+5.0(+0.59%)
Closed
4974 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
846.0854.0
52 wk Range
826.01,186.0
Key Statistics
Edit
Bid/Ask
850.00 / 852.00
Prev. Close
847
Open
850
Day's Range
846-854
52 wk Range
826-1,186
Volume
190.3K
Average Vol. (3m)
315.54K
1-Year Change
-14.55%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4974 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
1,266.7
Upside
+48.67%
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Biotechnology industry

Takara Bio Inc Company Profile

Takara Bio Inc., together with its subsidiaries, engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally. The company sells reagents and instruments, including genetic research reagents and testing kits; products related to coronavirus testing comprising in vitro diagnostics that detect viruses; analytical reagents; single-cell analysis systems; gene expression research reagents; fluorescent proteins series; genome-editing research reagents; iPS cell research reagents; and products for stem cell culturing and induction of differentiation under the TaKaRa, Clontech, and Cellartis brand names. It also provides contract services for regenerative medicine products, such as manufacturing of viral vectors and gene-transduced cells, quality and safety testing, and cell banking; and contract services for gene analysis and testing, including sequencing, intestinal flora analysis, comprehensive analysis of cancer-associated genes, and cell line creation through genome editing. In addition, the company is involved in developing platform technology for biologics development in areas, such as gene therapy. The company was incorporated in 2002 and is based in Kusatsu, Japan. Takara Bio Inc. is a subsidiary of Takara Holdings Inc.

Employees
1838
Market
Japan

Compare 4974 to Peers and Sector

Metrics to compare
4974
Peers
Sector
Relationship
P/E Ratio
−1,973.0x−5.7x−0.5x
PEG Ratio
19.10−0.290.00
Price / Book
0.9x4.3x2.6x
Price / LTM Sales
2.4x41.3x3.0x
Upside (Analyst Target)
17.4%69.9%55.6%
Fair Value Upside
Unlock17.0%10.1%Unlock

Analyst Ratings

1 Buy
2 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 1,266.7
(+48.67% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -0.43%
Dividend Yield
2.01%
Industry Median 0.45%
Annualized Payout
17.00
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Feb 13, 2025
EPS / Forecast
-15.71 / -6.00
Revenue / Forecast
9.52B / 11.10B
EPS Revisions
Last 90 days

FAQ

What Is the Takara Bio (4974) Stock Price Today?

The Takara Bio stock price today is 852.00

What Stock Exchange Does Takara Bio Trade On?

Takara Bio is listed and trades on the Tokyo stock exchange.

What Is the Stock Symbol for Takara Bio?

The stock symbol for Takara Bio is "4974."

Does Takara Bio Pay Dividends? What’s The Current Dividend Yield?

The Takara Bio dividend yield is 2.01%.

What Is the Takara Bio Market Cap?

As of today, Takara Bio market cap is 102.35B.

What is Takara Bio Earnings Per Share?

The Takara Bio EPS is -0.432.

What Is the Next Takara Bio Earnings Date?

Takara Bio will release its next earnings report on May 08, 2025.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.